TheEdgeResearch
Home / Stocks / LNMG

Linike Medical Group Ltd (LNMG)

OTC Consumer Cyclical Specialty Retail
$0.01 ▲ +0.00%
Market Cap
$3.3M
Sector
Consumer Cyclical
Industry
Specialty Retail
Beta
-3.13
52-Wk Range
0.0026-0.039
CEO
Jian Wang
Country
CN
Currency
USD

Linike Medical Group Ltd operates in the Specialty Retail industry of the Consumer Cyclical sector, headquartered in Chengdu, AB, CN. The stock last traded at $0.01, up 0.00% on the session, giving a market capitalisation of $3.3M. On trailing twelve-month figures it carries a trailing P/E of 3.57, a net margin of 13.9%. Its beta of -3.13 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
3.57
Price / Sales
0.53
Price / Book
0.09
EV / EBITDA
18.50
Gross margin
35.3%
Operating margin
13.9%
Net margin
13.9%
Return on equity
Debt / equity
0.43
Current ratio
4.86
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
0
IPO date
2012-06-12
Headquarters
Chengdu, AB, CN
About Linike Medical Group Ltd

Linike Medical Group Ltd. engages in the renewable energy business. The company is involved in the creation of a solar farm in India. It also focuses on commercial real estate development business. The company was formerly known as Litian Group Inc. and changed its name to Linike Medical Group Ltd. in August 2021. Linike Medical Group Ltd. is based in Calgary, Canada.

Comparable companies

Linike Medical Group Ltd is most often compared with the following Consumer Cyclical names:

ABVNBOREFDPXCFGFOOITRXPNXPFPSCOSLTNSPUPTCRI
More research on LNMG
LNMG technical analysis LNMG TheEdge Score Compare against peers
Open full interactive analysis & DCF →